2025 Partners
Lead Partner:
Serina Therapeutics
Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases. Serina’s POZ PlatformTM technology is engineered to provide greater control and precision in drug loading and the rate of release of attached drugs, enabling the potential of challenging small molecules, while addressing the limitations of other biocompatible polymers. POZ PlatformTM partners are at the forefront in advancing lipid nanoparticle (LNP) delivery technology to develop novel RNA therapeutics..
Expertise Partner:
ReciBioPharm
ReciBioPharm is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize advanced therapy medicinal products (ATMPs).
ReciBioPharm’s specialized CDMO capabilities include pre-clinical to clinical and commercial development and manufacture for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production.
Headed by a management team and technical experts with a proven track record in both process development and contract manufacturing, ReciBioPharm offers the knowledge and resources necessary to help customers develop and manufacture promising new therapies to meet the needs of patients across the world.
Program Partners:
Corden Pharma
CordenPharma offers advanced LNP formulation technologies, back-integrated lipid synthesis, and forward-integrated sterile injectable manufacturing services to create a proven, truly integrated, commercialization pathway for your xRNA based therapeutics. Our LNP manufacturing strategies, based on ethanol injection, are tailored to encapsulate a broad variety of genetic payloads. We also offer LNP Starter Kits (which provide researchers the essential components needed to create and optimize their own LNPs for xRNA/xDNA delivery), key standard and proprietary lipids ideally suited for mRNA applications, and support sterile injectable PFS, vials, ampoules & lyophilized vials with a wide range of filling volumes.
MilliporeSigma
MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. We provide solutions to help you overcome your mRNA manufacturing and LNP formulation challenges. Our integrated CTDMO capabilities include the development and manufacturing of custom mRNAs, synthetic lipids, lipid nanoparticle (LNP) formulation and fill and finish. Discover how our capabilities, technical expertise and regulatory know-how can help you deliver and scale up your mRNA-based vaccines and therapeutics, accelerate time to market and mitigate risks.
www.SigmaAldrich.com/MilliporeCTDMOServices
FUJIFILM
FUJIFILM Corporation is transforming into a healthcare company through leveraging fine-chemical technologies cultivated in photo-films’ manufacturing, such as organic-chemistry and nanotechnologies. Based on these assets, we have started one-stop CDMO service from bench top formulation research to GMP manufacturing for lipid nanoparticles utilizing Fujifilm's proprietary ionizable lipids.
Lipoid
Since its foundation in 1977, Lipoid has gained an outstanding reputation in the development and industrial production of high-quality lecithin, phospholipids, and other lipid products, meeting the high standards of the pharmaceutical industry. Lipoid is the world’s leading company for the production and supply of a wide range of natural and synthetic phospholipid excipients on an industrial scale.
NOF
NOF CORPORATION is the leading commercial supplier of GMP grade activated PEGs, lipids and ultrapure Polysorbates 80 for drug delivery products through R&D to commercial scale. We provide a wide range of lipids (ionizable, PEG, and phospho) for lipid nanoparticle formulations (LNP). Our LNP platform, containing our ionizable lipid (COATSOME® SS Series), has excellent endosomal escape ability and provides high gene expression with low toxicity. It is capable of applying to gene delivery, gene editing, and RNA vaccine application under this platform.
Innovation Partners:
JenKem Technology
JenKem Technology manufactures small molecules, lipids, and related PEG-lipid intermediates for LNPs used for mRNA delivery, as well as for Cell Penetrating Peptide PEG products for siRNA delivery.
JenKem Technology supplies PEG derivatives worldwide, from R&D through preclinical, clinical trials, and GMP commercial quantities for pharmaceuticals, biotech, medical devices, and diagnostics. DMFs were filed with China CDE and US FDA for several of these products. PEGylation services are available up to pre-clinical stage.
Exhibition Partners:
ABITEC
Ardena
Ardena is your premier integrated CDMO and leading nanomedicine partner, with a special focus on LNP (Lipid Nanoparticle) development. Our unparalleled service portfolio encompasses the entire LNP lifecycle, from early development to GMP manufacturing of payloads and LNPs. Additionally, we offer GMP aseptic fill-finish, clinical packaging, bioanalysis, and CMC regulatory support. Experience the seamless journey from concept to clinic with Ardena's comprehensive and expertly integrated LNP services.
Avanti Polar Lipids
Whatever your requirement, Croda Pharma’s extensive portfolio of Avanti lipids can meet your needs. We offer both research grade and GMP grade lipids to support discovery, clinical, and commercial LNP manufacturing requirements including an extensive portfolio of phospholipids, PEG lipids, cationic lipids, functionalized lipids, sterols, and more. In addition, we specialize in custom lipid manufacturing of proprietary compounds, lipid formulation development, and preparation of custom lipid blends to make your project a success.
Cayman Chemical
Partner with Cayman and utilize 42 years’ experience in synthesis, purification, and characterization of lipids. Cayman manufactures an expansive selection of high-purity lipids utilized in LNP and liposome development including commercial and custom phospholipids, cationic and, anionic lipids. Our client-focused services include custom synthesis, purification, characterization, and custom API manufacturing. We couple your vision with our expertise to match your payload with the world’s best lipids and lipid chemists.
Helix Biotech
Helix Biotech is a Customer and Quality focused CDMO specializing in LNPs, Liposomes, and Hybrid Nanoparticles. Browse our selection of innovative tools and reagent systems, or reach out to us for assistance with your pre-clinical or clinical stage development, manufacturing, and analytical project.
Spectradyne
Spectradyne’s ARC™️ nanoparticle analysis system combines two orthogonal methods in a single system, for LNP size, concentration, payload analysis and surface targeting information. The ARC system overcomes all the limitations found with other technologies such as fluorescence NTA and flow cytometry.
- Simultaneous particle size, concentration & fluorescence-based phenotyping/payload measurement
- Electrical & optical: Simultaneous orthogonal measurements
- Quantitative, traceable fluorescence units (ERF or MESF)
- Compatible with traditional dyes & staining protocols (no wash steps required)
- Microliter sample sizes
- Works in complex backgrounds (serum, plasma)
KNAUER
KNAUER are a berlin-based manufacturer of high-tech scientific instruments, whose strength lies in liquid engineering.
KNAUER manufactures systems for the production of lipid nanoparticle-based formulations, such as mRNA vaccines. Their NanoProducer units, which use KNAUER’s Impingement Jets Mixing (IJM) technology, are used worldwide in the high-volume production of mRNA COVID-19 vaccines.
Their latest LNP system, the NanoScaler, is designed specifically for the pre-scale up R&D of new mRNA therapies.
Think LNP. Think KNAUER.
Micro&Nano
Micro&Nano Biologics Co.,LTD. was formally established in early 2020 when founded in 2018. Micro & Nano is a company focusing on providing integrated solutions for the development of nano delivery of genomic medicines and has acquired more than 20 invention patents (PCT included) in related field.
Micro & Nano has built the first integrated nucleic acid delivery process equipment R&D and production center in Shanghai, which can provide process and customization support to customers. The company is now focusing on RNA drug delivery equipment (laboratory to cGMP production) and process development, production, manufacturing, and has served more than 200 head pharmaceutical companies and research institutes at home and abroad, which has helped many customers to obtain IND clinical approvals for nucleic acid drugs in China, the United States, Brazil, Australia, etc.
ONI
Founded in 2016, ONI is now a leading and rapidly growing life science company redefining the boundaries of scientific discovery with super-resolution microscopy. The Nanoimager, ONI’s flagship product, is the world’s first desktop super-resolution microscope, capable of visualizing, tracking and imaging individual molecules in living cells with 20 nm resolution. Each team at ONI – from scientists to software engineers to sales teams – wants to create and provide innovative technologies that will empower researchers and users alike. We want to accelerate human discovery and fight disease and in doing so drive super-resolution microscopy to novel frontiers.
Sinopeg
Xiamen Sinopeg Biotech Co., Ltd. is dedicated to drug delivery systems and related medical device business, focusing on the research, development, production and sales of high-end drug delivery carriers/auxiliary materials/APIs, medical materials, including but not limited to polyethylene glycol derivatives, lipid products, blood sugar control drug modifiers, block copolymers, ADC/ProTAC linkers, biodegradable polymers, exosomes, viral-like particles, as well as providing CDMO and solution services. These products are widely used in long-acting protein/peptide drugs, COVID-19 mRNA vaccines, small nucleic acid drugs, blood sugar control drugs, macromolecular micelle drugs, liposome drugs, gene therapy drugs, immunosuppressants, ADC drugs, ProTAC drugs, medical hydrogels, and other fields, placing the company in a leading position in the industry.
SINOPEG holds 31 IP, 25 pending IP, and 16 DMFs that meet FDA requirements. The company has ISO13485 certification. The laboratory and production workshop are designed and built in accordance with the cGMP standard of FDA. We follow the requirements of ICH-Q7A to organize production at scale, to provide high quality polyethylene glycol derivatives products and services to customers globally.
Phosphorex
Phosphorex is a leading provider of drug delivery technologies and solutions. By harnessing the potential of microspheres and nanoparticles for drug delivery, Phosphorex offers tailored solutions and enabling technologies to optimize a drug's release rate, targeting ability, bioavailability, and deliverability, with the goal of achieving desired therapeutic effects while reducing adverse clinical outcomes. Phosphorex supports pharmaceutical and biotech companies through all phases of their development, from proof of concept to clinical studies. Phosphorex's mission is to help our partners solve complex problems and develop successful drugs to help patients.
NanoFCM
NanoFCM is helping scientists deliver the next generation of nanomedicines by providing reliable quantitative measurements of the single nanoparticle size, concentration, and phenotyping. We are enabling new methods of nanoparticle analysis, providing invaluable data for process and product development from research stage through commercial release.